Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical neomycin for acute cystitis in patients with permanent bladder catheter
2011-004594-82Phase 3Terminated
- Sponsor
- Schur Pharmazeutika GmbH & Co. KG
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of neomycin in acute cystitis and urinary tract infection (UTI) (2 arms), sponsored by Schur Pharmazeutika GmbH & Co. KG. Primary endpoint: Proportion of patients with urine bacterial count below 10^5 CFU/mL. Started Oct 2011; status: terminated.
02
Drugs
neomycin
03
Conditions
acute cystitisurinary tract infection (UTI)
Beyond the preview
Go deeper on 2011-004594-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004594-82.